Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2011, Article ID 240328, 7 pages
http://dx.doi.org/10.4061/2011/240328
Research Article

Testosterone and the Male Skeleton: A Dual Mode of Action

1Experimental Medicine and Endocrinology, Department of Experimental Medicine, K. U. Leuven, 300 Leuven, Belgium
2Division of Geriatric Medicine, Leuven University Hospital, Leuven, 300 Leuven, Belgium
3Gerontology and Geriatrics Section, Department of Experimental Medicine, K. U. Leuven, 300 Leuven, Belgium
4Leuven University Centre for Metabolic Bone Diseases, 300 Leuven, Belgium
5Molecular Endocrinology Laboratory, Department of Molecular Cell Biology, K. U. Leuven, 300 Leuven, Belgium
6Laboratory for Experimental Medicine and Endocrinology, Leuven University Hospital, Herestraat 49, 300 Leuven, Belgium

Received 13 April 2011; Accepted 4 July 2011

Academic Editor: Pawel Szulc

Copyright © 2011 Mieke Sinnesael et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson, “Androgens and bone,” Endocrine Reviews, vol. 25, no. 3, pp. 389–425, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. P. Smith, B. Specker, B. E. Bachrach et al., “Impact on bone of an estrogen receptor-α gene loss of function mutation,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 3088–3096, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. Lanfranco, L. Zirilli, M. Baldi et al., “A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment,” Bone, vol. 43, no. 3, pp. 628–635, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, and C. Carani, “Human models of aromatase deficiency,” Journal of Steroid Biochemistry and Molecular Biology, vol. 109, no. 3–5, pp. 212–218, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Bouillon, M. Bex, D. Vanderschueren, and S. Boonen, “Estrogens are essential for male pubertal periosteal bone expansion,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6025–6029, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Khosla, L. J. Melton III, and B. L. Riggs, “The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?” Journal of Bone and Mineral Research, vol. 26, no. 3, pp. 441–451, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. Y. Taes, B. Lapauw, S. Vandewalle et al., “Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity,” Bone, vol. 45, no. 2, pp. 392–397, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. E. Barrett-Connor, J. E. Mueller, D. G. Von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris, “Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo study,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 1, pp. 219–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Meier, T. V. Nguyen, D. J. Handelsman et al., “Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology study,” Archives of Internal Medicine, vol. 168, no. 1, pp. 47–54, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. Bjornerem, L. A. Ahmed, R. M. Joakimsen et al., “A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso study,” European Journal of Endocrinology, vol. 157, no. 1, pp. 119–125, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. H. W. Goderie-Plomp, M. Van Der Klift, W. De Ronde, A. Hofman, F. H. De Jong, and H. A. P. Pols, “Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam study,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3261–3269, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Amin, Y. Zhang, D. T. Felson et al., “Estradiol, testosterone, and the risk for hip fractures in elderly men from the framingham study,” American Journal of Medicine, vol. 119, no. 5, pp. 426–433, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. D. Mellström, L. Vandenput, H. Mallmin et al., “Older men with low serum estradiol and high serum SHBG have an increased risk of fractures,” Journal of Bone and Mineral Research, vol. 23, no. 10, pp. 1552–1560, 2008. View at Publisher · View at Google Scholar · View at PubMed
  14. L. Gennari, S. Khosla, and J. P. Bilezikian, “Estrogen and fracture risk in men,” Journal of Bone and Mineral Research, vol. 23, no. 10, pp. 1548–1551, 2008. View at Publisher · View at Google Scholar · View at PubMed
  15. P. Szulc, B. Claustrat, F. Munoz, F. Marchand, and P. D. Delmas, “Assessment of the role of 17β-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study,” Clinical Endocrinology, vol. 61, no. 4, pp. 447–457, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Khosla, L. Joseph Melton, and B. Lawrence Riggs, “Clinical review 144: estrogen and the male skeleton,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1443–1450, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Falahati-Nini, B. L. Riggs, E. J. Atkinson, W. M. O'Fallon, R. Eastell, and S. Khosla, “Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men,” Journal of Clinical Investigation, vol. 106, no. 12, pp. 1553–1560, 2000. View at Google Scholar · View at Scopus
  18. B. Z. Leder, K. M. LeBlanc, D. A. Schoenfeld, R. Eastell, and J. S. Finkelstein, “Differential effects of androgens and estrogens on bone turnover in normal men,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 1, pp. 204–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. Limer, S. R. Pye, W. Thomson et al., “Genetic variation in sex hormone genes influences heel ultrasound parameters in middle-aged and elderly men: results from the European Male Aging study (EMAS),” Journal of Bone and Mineral Research, vol. 24, no. 2, pp. 314–323, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. L. P. Ly and D. J. Handelsman, “Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays,” European Journal of Endocrinology, vol. 152, no. 3, pp. 471–478, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. E. S. LeBlanc, C. M. Nielson, L. M. Marshall et al., “The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3337–3346, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Lorentzon, C. Swanson, N. Andersson, D. Mellström, and C. Ohlsson, “Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study,” Journal of Bone and Mineral Research, vol. 20, no. 8, pp. 1334–1341, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. Vanbillemont, B. Lapauw, V. Bogaert et al., “Sex hormone-binding globulin as an independent determinant of cortical bone status in men at the age of peak bone mass,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1579–1586, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. Khosla, S. Amin, and E. Orwoll, “Osteoporosis in men,” Endocrine Reviews, vol. 29, no. 4, pp. 441–464, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. H. W. Daniell, S. R. Dunn, D. W. Ferguson, G. Lomas, Z. Niazi, and P. T. Stratte, “Progressive osteoporosis during androgen deprivation therapy for prostate cancer,” Journal of Urology, vol. 163, no. 1, pp. 181–186, 2000. View at Google Scholar · View at Scopus
  26. D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson, “Androgens and bone,” Endocrine Reviews, vol. 25, no. 3, pp. 389–425, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. M. Isidori, E. Giannetta, E. A. Greco et al., “Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis,” Clinical Endocrinology, vol. 63, no. 3, pp. 280–293, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. R. Smith, M. A. Fallon, H. Lee, and J. S. Finkelstein, “Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3841–3846, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. B. Z. Leder and J. S. Finkelstein, “Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men,” Osteoporosis International, vol. 16, no. 12, pp. 1487–1494, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. A. M. Burnett-Bowie, E. A. McKay, H. Lee, and B. Z. Leder, “Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 4785–4792, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Yang, Z. Wu, D. Wu et al., “Pharmacokinetics, biodistribution and metabolism of a novel selective androgen receptor modulator designed for prostate cancer imaging,” International Journal of Oncology, vol. 36, no. 1, pp. 213–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. G. K. Wakley, H. D. Schutte, K. S. Hannon, and R. T. Turner, “Androgen treatment prevents loss of cancellous bone in the orchidectomized rat,” Journal of Bone and Mineral Research, vol. 6, no. 4, pp. 325–330, 1991. View at Google Scholar · View at Scopus
  33. D. Vanderschueren, E. Van Herck, A. M. H. Suiker, W. J. Visser, L. P. C. Schot, and R. Bouillon, “Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency,” Endocrinology, vol. 130, no. 5, pp. 2906–2916, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Prakasam, J. K. Yeh, M. M. Chen, M. Castro-Magana, C. T. Liang, and J. F. Aloia, “Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats,” Bone, vol. 24, no. 5, pp. 491–497, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. R. T. Turner, G. K. Wakley, and K. S. Hannon, “Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats,” Journal of Orthopaedic Research, vol. 8, no. 4, pp. 612–617, 1990. View at Google Scholar · View at Scopus
  36. L. Vandenput, S. Boonen, E. Van Herck, J. V. Swinnen, R. Bouillon, and D. Vanderschueren, “Evidence from the aged orchidectomized male rat model that 17β-estradiol is a more effective bone-sparing and anabolic agent than 5α-dihydrotestosterone,” Journal of Bone and Mineral Research, vol. 17, no. 11, pp. 2080–2086, 2002. View at Google Scholar · View at Scopus
  37. N. Gaumet-Meunier, V. Coxam, S. Robins et al., “Gonadal steroids and bone metabolism in young castrated male rats,” Calcified Tissue International, vol. 66, no. 6, pp. 470–475, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. U. I. L. Mödder, B. L. Riggs, T. C. Spelsberg et al., “Dose-response of estrogen on bone versus the uterus in ovariectomized mice,” European Journal of Endocrinology, vol. 151, no. 4, pp. 503–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Frenkel, A. Hong, S. K. Baniwal et al., “Regulation of adult bone turnover by sex steroids,” Journal of Cellular Physiology, vol. 224, no. 2, pp. 305–310, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. L. E. Olson, C. Ohlsson, and S. Mohan, “The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice,” Calcified Tissue International, vol. 88, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. F. Callewaert, K. Venken, J. Ophoff et al., “Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-α,” FASEB Journal, vol. 23, no. 1, pp. 232–240, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. N. A. Sims, S. Dupont, A. Krust et al., “Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-β in bone remodeling in females but not in males,” Bone, vol. 30, no. 1, pp. 18–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. A. J. Notini, J. F. McManus, A. Moore et al., “Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice,” Journal of Bone and Mineral Research, vol. 22, no. 3, pp. 347–356, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. C. Chiang, M. Chiu, A. J. Moore et al., “Mineralization and bone resorption are regulated by the androgen receptor in male mice,” Journal of Bone and Mineral Research, vol. 24, no. 4, pp. 621–631, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. H. Kawano, T. Sato, T. Yamada et al., “Suppressive function of androgen receptor in bone resorption,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9416–9421, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus